nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—Conjugated Estrogens—prostate cancer	0.15	0.532	CbGbCtD
Baclofen—SLC22A8—Estradiol—prostate cancer	0.132	0.467	CbGbCtD
Baclofen—SLC22A8—urine—prostate cancer	0.0134	0.171	CbGeAlD
Baclofen—GABBR1—prostate gland—prostate cancer	0.0121	0.156	CbGeAlD
Baclofen—GABBR2—testis—prostate cancer	0.0106	0.136	CbGeAlD
Baclofen—GABBR1—seminal vesicle—prostate cancer	0.0103	0.132	CbGeAlD
Baclofen—GABBR1—urethra—prostate cancer	0.00813	0.104	CbGeAlD
Baclofen—GABBR1—bone marrow—prostate cancer	0.00626	0.0802	CbGeAlD
Baclofen—GABBR1—testis—prostate cancer	0.00535	0.0685	CbGeAlD
Baclofen—SLC22A8—prostate gland—prostate cancer	0.0048	0.0614	CbGeAlD
Baclofen—GABBR1—lymph node—prostate cancer	0.00388	0.0497	CbGeAlD
Baclofen—SLC22A8—renal system—prostate cancer	0.00327	0.0419	CbGeAlD
Baclofen—Chlorphenesin—CYP19A1—prostate cancer	0.00151	0.217	CrCbGaD
Baclofen—Ibuprofen—BCL2—prostate cancer	0.00133	0.191	CrCbGaD
Baclofen—Ibuprofen—CXCL8—prostate cancer	0.00106	0.153	CrCbGaD
Baclofen—Chlorpropamide—CYP2C19—prostate cancer	0.000847	0.122	CrCbGaD
Baclofen—Chlorphenesin—CYP3A4—prostate cancer	0.00071	0.102	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—prostate cancer	0.000696	0.0999	CrCbGaD
Baclofen—Ibuprofen—CYP2C19—prostate cancer	0.000499	0.0716	CrCbGaD
Baclofen—Ibuprofen—PTGS2—prostate cancer	0.00031	0.0446	CrCbGaD
Baclofen—GABBR2—Signaling Pathways—PLCB2—prostate cancer	0.000187	0.00112	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LRP2—prostate cancer	0.000187	0.00112	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GNG5—prostate cancer	0.000185	0.00111	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL8—prostate cancer	0.000185	0.00111	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—ADRB2—prostate cancer	0.000185	0.0011	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CX3CL1—prostate cancer	0.000184	0.0011	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—P4HB—prostate cancer	0.000184	0.0011	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—VAV3—prostate cancer	0.00018	0.00108	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HIST1H2BG—prostate cancer	0.00018	0.00108	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDE4D—prostate cancer	0.000179	0.00107	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRB7—prostate cancer	0.000179	0.00107	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PTHLH—prostate cancer	0.000178	0.00106	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—ITPR1—prostate cancer	0.000175	0.00104	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—WNT4—prostate cancer	0.000174	0.00104	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HIST1H4H—prostate cancer	0.000174	0.00104	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JUP—prostate cancer	0.000174	0.00104	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—prostate cancer	0.000174	0.00104	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—MDM2—prostate cancer	0.000173	0.00103	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GNG5—prostate cancer	0.00017	0.00101	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ANXA1—prostate cancer	0.000167	0.000999	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RALBP1—prostate cancer	0.000166	0.000992	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MC2R—prostate cancer	0.000166	0.000992	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000166	0.000989	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTHLH—prostate cancer	0.000161	0.000965	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRKACB—prostate cancer	0.000158	0.000944	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CALCA—prostate cancer	0.000156	0.000935	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PPP3CA—prostate cancer	0.000154	0.00092	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL12—prostate cancer	0.000153	0.000913	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000153	0.000913	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ANXA1—prostate cancer	0.000152	0.000907	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTHLH—prostate cancer	0.000148	0.000884	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PENK—prostate cancer	0.000148	0.000884	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFBR1—prostate cancer	0.000148	0.000884	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKR1C3—prostate cancer	0.000146	0.00087	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKACB—prostate cancer	0.000145	0.000865	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CALCA—prostate cancer	0.000142	0.000849	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—THBS1—prostate cancer	0.000141	0.000844	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GHR—prostate cancer	0.000141	0.000844	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PPP3CA—prostate cancer	0.000141	0.000844	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000139	0.000833	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ANXA1—prostate cancer	0.000139	0.000831	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL12—prostate cancer	0.000139	0.000829	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCZ—prostate cancer	0.000137	0.000816	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NRP1—prostate cancer	0.000135	0.000809	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000135	0.000806	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CG—prostate cancer	0.000133	0.000798	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGFR4—prostate cancer	0.000132	0.000788	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PARP1—prostate cancer	0.000132	0.000788	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADRB2—prostate cancer	0.000131	0.000784	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CALCA—prostate cancer	0.00013	0.000778	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000128	0.000767	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—VAV3—prostate cancer	0.000128	0.000764	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL12—prostate cancer	0.000127	0.00076	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRKCQ—prostate cancer	0.000127	0.000757	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GNRH1—prostate cancer	0.000126	0.000752	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VIP—prostate cancer	0.000126	0.000752	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ITPR1—prostate cancer	0.000124	0.000741	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRP—prostate cancer	0.000122	0.000728	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LPAR1—prostate cancer	0.000122	0.000728	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—prostate cancer	0.000121	0.000724	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PLCB2—prostate cancer	0.000121	0.000721	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LRP2—prostate cancer	0.000121	0.000721	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP9—prostate cancer	0.00012	0.000716	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ADRB2—prostate cancer	0.000119	0.000712	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CX3CL1—prostate cancer	0.000118	0.000707	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—P4HB—prostate cancer	0.000118	0.000707	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CD—prostate cancer	0.000117	0.000701	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—VAV3—prostate cancer	0.000116	0.000694	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCQ—prostate cancer	0.000116	0.000694	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NGFR—prostate cancer	0.000116	0.000694	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIST1H2BG—prostate cancer	0.000116	0.000694	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRB7—prostate cancer	0.000115	0.000688	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDE4D—prostate cancer	0.000115	0.000688	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAP3K7—prostate cancer	0.000115	0.000686	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ITPR1—prostate cancer	0.000113	0.000673	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIST1H4H—prostate cancer	0.000112	0.00067	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—prostate cancer	0.000112	0.00067	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF10—prostate cancer	0.00011	0.000659	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GNG5—prostate cancer	0.000109	0.000654	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000109	0.000654	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADRB2—prostate cancer	0.000109	0.000652	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—JAK2—prostate cancer	0.000108	0.000643	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAP2K1—prostate cancer	0.000107	0.000641	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CD—prostate cancer	0.000107	0.000637	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VAV3—prostate cancer	0.000106	0.000636	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFBR2—prostate cancer	0.000105	0.000627	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ITPR1—prostate cancer	0.000103	0.000617	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000103	0.000616	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CB—prostate cancer	0.000102	0.000611	CbGpPWpGaD
Baclofen—Urinary tract disorder—Epirubicin—prostate cancer	9.99e-05	0.000215	CcSEcCtD
Baclofen—Hyperhidrosis—Capecitabine—prostate cancer	9.98e-05	0.000214	CcSEcCtD
Baclofen—Oedema peripheral—Epirubicin—prostate cancer	9.97e-05	0.000214	CcSEcCtD
Baclofen—Hypotension—Docetaxel—prostate cancer	9.96e-05	0.000214	CcSEcCtD
Baclofen—Haematuria—Doxorubicin—prostate cancer	9.94e-05	0.000214	CcSEcCtD
Baclofen—Connective tissue disorder—Epirubicin—prostate cancer	9.94e-05	0.000214	CcSEcCtD
Baclofen—Urethral disorder—Epirubicin—prostate cancer	9.92e-05	0.000213	CcSEcCtD
Baclofen—Loss of consciousness—Prednisone—prostate cancer	9.9e-05	0.000213	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—IGF1R—prostate cancer	9.87e-05	0.00059	CbGpPWpGaD
Baclofen—Hepatobiliary disease—Doxorubicin—prostate cancer	9.86e-05	0.000212	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.84e-05	0.000588	CbGpPWpGaD
Baclofen—Anorexia—Capecitabine—prostate cancer	9.84e-05	0.000211	CcSEcCtD
Baclofen—Nausea—Estradiol—prostate cancer	9.83e-05	0.000211	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—prostate cancer	9.83e-05	0.000587	CbGpPWpGaD
Baclofen—Vomiting—Mitoxantrone—prostate cancer	9.8e-05	0.000211	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—JAK2—prostate cancer	9.78e-05	0.000584	CbGpPWpGaD
Baclofen—Convulsion—Prednisone—prostate cancer	9.76e-05	0.00021	CcSEcCtD
Baclofen—Visual impairment—Epirubicin—prostate cancer	9.75e-05	0.00021	CcSEcCtD
Baclofen—Hypertension—Prednisone—prostate cancer	9.72e-05	0.000209	CcSEcCtD
Baclofen—Rash—Mitoxantrone—prostate cancer	9.72e-05	0.000209	CcSEcCtD
Baclofen—Dermatitis—Mitoxantrone—prostate cancer	9.71e-05	0.000209	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.71e-05	0.000209	CcSEcCtD
Baclofen—Headache—Mitoxantrone—prostate cancer	9.66e-05	0.000208	CcSEcCtD
Baclofen—Hypotension—Capecitabine—prostate cancer	9.64e-05	0.000207	CcSEcCtD
Baclofen—Insomnia—Docetaxel—prostate cancer	9.64e-05	0.000207	CcSEcCtD
Baclofen—Myalgia—Prednisone—prostate cancer	9.59e-05	0.000206	CcSEcCtD
Baclofen—Paraesthesia—Docetaxel—prostate cancer	9.57e-05	0.000206	CcSEcCtD
Baclofen—Anxiety—Prednisone—prostate cancer	9.56e-05	0.000205	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TGFBR1—prostate cancer	9.54e-05	0.00057	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTHLH—prostate cancer	9.54e-05	0.00057	CbGpPWpGaD
Baclofen—Bradycardia—Doxorubicin—prostate cancer	9.53e-05	0.000205	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	9.52e-05	0.000205	CcSEcCtD
Baclofen—Dyspnoea—Docetaxel—prostate cancer	9.5e-05	0.000204	CcSEcCtD
Baclofen—Somnolence—Docetaxel—prostate cancer	9.48e-05	0.000204	CcSEcCtD
Baclofen—Discomfort—Prednisone—prostate cancer	9.47e-05	0.000204	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—LPL—prostate cancer	9.47e-05	0.000566	CbGpPWpGaD
Baclofen—Eye disorder—Epirubicin—prostate cancer	9.46e-05	0.000203	CcSEcCtD
Baclofen—Tinnitus—Epirubicin—prostate cancer	9.43e-05	0.000203	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.4e-05	0.000202	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—IL2—prostate cancer	9.39e-05	0.000561	CbGpPWpGaD
Baclofen—Cardiac disorder—Epirubicin—prostate cancer	9.39e-05	0.000202	CcSEcCtD
Baclofen—Flushing—Epirubicin—prostate cancer	9.39e-05	0.000202	CcSEcCtD
Baclofen—Rhinitis—Doxorubicin—prostate cancer	9.39e-05	0.000202	CcSEcCtD
Baclofen—Dyspepsia—Docetaxel—prostate cancer	9.38e-05	0.000202	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PDGFRB—prostate cancer	9.38e-05	0.000561	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKR1C3—prostate cancer	9.38e-05	0.000561	CbGpPWpGaD
Baclofen—Insomnia—Capecitabine—prostate cancer	9.33e-05	0.000201	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PRKACB—prostate cancer	9.33e-05	0.000558	CbGpPWpGaD
Baclofen—Hypoaesthesia—Doxorubicin—prostate cancer	9.32e-05	0.0002	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CB—prostate cancer	9.29e-05	0.000555	CbGpPWpGaD
Baclofen—Paraesthesia—Capecitabine—prostate cancer	9.27e-05	0.000199	CcSEcCtD
Baclofen—Decreased appetite—Docetaxel—prostate cancer	9.27e-05	0.000199	CcSEcCtD
Baclofen—Urinary tract disorder—Doxorubicin—prostate cancer	9.25e-05	0.000199	CcSEcCtD
Baclofen—Oedema peripheral—Doxorubicin—prostate cancer	9.22e-05	0.000198	CcSEcCtD
Baclofen—Gastrointestinal disorder—Docetaxel—prostate cancer	9.2e-05	0.000198	CcSEcCtD
Baclofen—Asthenia—Etoposide—prostate cancer	9.2e-05	0.000198	CcSEcCtD
Baclofen—Connective tissue disorder—Doxorubicin—prostate cancer	9.2e-05	0.000198	CcSEcCtD
Baclofen—Dyspnoea—Capecitabine—prostate cancer	9.2e-05	0.000198	CcSEcCtD
Baclofen—Oedema—Prednisone—prostate cancer	9.19e-05	0.000197	CcSEcCtD
Baclofen—Fatigue—Docetaxel—prostate cancer	9.19e-05	0.000197	CcSEcCtD
Baclofen—Angiopathy—Epirubicin—prostate cancer	9.18e-05	0.000197	CcSEcCtD
Baclofen—Urethral disorder—Doxorubicin—prostate cancer	9.18e-05	0.000197	CcSEcCtD
Baclofen—Nausea—Mitoxantrone—prostate cancer	9.16e-05	0.000197	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ITGB3—prostate cancer	9.14e-05	0.000546	CbGpPWpGaD
Baclofen—Infection—Prednisone—prostate cancer	9.13e-05	0.000196	CcSEcCtD
Baclofen—Mediastinal disorder—Epirubicin—prostate cancer	9.12e-05	0.000196	CcSEcCtD
Baclofen—Pain—Docetaxel—prostate cancer	9.11e-05	0.000196	CcSEcCtD
Baclofen—Constipation—Docetaxel—prostate cancer	9.11e-05	0.000196	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PPP3CA—prostate cancer	9.1e-05	0.000544	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—THBS1—prostate cancer	9.1e-05	0.000544	CbGpPWpGaD
Baclofen—Dyspepsia—Capecitabine—prostate cancer	9.08e-05	0.000195	CcSEcCtD
Baclofen—Chills—Epirubicin—prostate cancer	9.08e-05	0.000195	CcSEcCtD
Baclofen—Pruritus—Etoposide—prostate cancer	9.07e-05	0.000195	CcSEcCtD
Baclofen—Shock—Prednisone—prostate cancer	9.04e-05	0.000194	CcSEcCtD
Baclofen—Arrhythmia—Epirubicin—prostate cancer	9.04e-05	0.000194	CcSEcCtD
Baclofen—Visual impairment—Doxorubicin—prostate cancer	9.02e-05	0.000194	CcSEcCtD
Baclofen—Nervous system disorder—Prednisone—prostate cancer	9.01e-05	0.000194	CcSEcCtD
Baclofen—Tachycardia—Prednisone—prostate cancer	8.97e-05	0.000193	CcSEcCtD
Baclofen—Decreased appetite—Capecitabine—prostate cancer	8.97e-05	0.000193	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ANXA1—prostate cancer	8.97e-05	0.000536	CbGpPWpGaD
Baclofen—Alopecia—Epirubicin—prostate cancer	8.94e-05	0.000192	CcSEcCtD
Baclofen—Skin disorder—Prednisone—prostate cancer	8.93e-05	0.000192	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—prostate cancer	8.93e-05	0.000533	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Capecitabine—prostate cancer	8.91e-05	0.000191	CcSEcCtD
Baclofen—Fatigue—Capecitabine—prostate cancer	8.9e-05	0.000191	CcSEcCtD
Baclofen—Hyperhidrosis—Prednisone—prostate cancer	8.89e-05	0.000191	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ERBB3—prostate cancer	8.87e-05	0.00053	CbGpPWpGaD
Baclofen—Mental disorder—Epirubicin—prostate cancer	8.87e-05	0.00019	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FGFR2—prostate cancer	8.85e-05	0.000529	CbGpPWpGaD
Baclofen—Pain—Capecitabine—prostate cancer	8.82e-05	0.00019	CcSEcCtD
Baclofen—Constipation—Capecitabine—prostate cancer	8.82e-05	0.00019	CcSEcCtD
Baclofen—Malnutrition—Epirubicin—prostate cancer	8.81e-05	0.000189	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PRKCZ—prostate cancer	8.8e-05	0.000526	CbGpPWpGaD
Baclofen—Feeling abnormal—Docetaxel—prostate cancer	8.78e-05	0.000189	CcSEcCtD
Baclofen—Diarrhoea—Etoposide—prostate cancer	8.78e-05	0.000189	CcSEcCtD
Baclofen—Anorexia—Prednisone—prostate cancer	8.76e-05	0.000188	CcSEcCtD
Baclofen—Eye disorder—Doxorubicin—prostate cancer	8.75e-05	0.000188	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—prostate cancer	8.73e-05	0.000188	CcSEcCtD
Baclofen—Gastrointestinal pain—Docetaxel—prostate cancer	8.72e-05	0.000187	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.69e-05	0.000519	CbGpPWpGaD
Baclofen—Cardiac disorder—Doxorubicin—prostate cancer	8.69e-05	0.000187	CcSEcCtD
Baclofen—Flushing—Doxorubicin—prostate cancer	8.69e-05	0.000187	CcSEcCtD
Baclofen—Flatulence—Epirubicin—prostate cancer	8.68e-05	0.000186	CcSEcCtD
Baclofen—Dysgeusia—Epirubicin—prostate cancer	8.63e-05	0.000185	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—prostate cancer	8.6e-05	0.000514	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL2—prostate cancer	8.53e-05	0.00051	CbGpPWpGaD
Baclofen—Back pain—Epirubicin—prostate cancer	8.52e-05	0.000183	CcSEcCtD
Baclofen—Feeling abnormal—Capecitabine—prostate cancer	8.5e-05	0.000183	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PARP1—prostate cancer	8.5e-05	0.000508	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TERT—prostate cancer	8.5e-05	0.000508	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGFR4—prostate cancer	8.5e-05	0.000508	CbGpPWpGaD
Baclofen—Angiopathy—Doxorubicin—prostate cancer	8.49e-05	0.000183	CcSEcCtD
Baclofen—Dizziness—Etoposide—prostate cancer	8.48e-05	0.000182	CcSEcCtD
Baclofen—Gastrointestinal pain—Capecitabine—prostate cancer	8.44e-05	0.000181	CcSEcCtD
Baclofen—Mediastinal disorder—Doxorubicin—prostate cancer	8.44e-05	0.000181	CcSEcCtD
Baclofen—Abdominal pain—Docetaxel—prostate cancer	8.43e-05	0.000181	CcSEcCtD
Baclofen—Body temperature increased—Docetaxel—prostate cancer	8.43e-05	0.000181	CcSEcCtD
Baclofen—Chills—Doxorubicin—prostate cancer	8.4e-05	0.00018	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CALCA—prostate cancer	8.4e-05	0.000502	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Prednisone—prostate cancer	8.37e-05	0.00018	CcSEcCtD
Baclofen—Arrhythmia—Doxorubicin—prostate cancer	8.36e-05	0.00018	CcSEcCtD
Baclofen—Insomnia—Prednisone—prostate cancer	8.31e-05	0.000179	CcSEcCtD
Baclofen—Vision blurred—Epirubicin—prostate cancer	8.3e-05	0.000178	CcSEcCtD
Baclofen—Alopecia—Doxorubicin—prostate cancer	8.27e-05	0.000178	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	8.27e-05	0.000494	CbGpPWpGaD
Baclofen—Paraesthesia—Prednisone—prostate cancer	8.25e-05	0.000177	CcSEcCtD
Baclofen—Mental disorder—Doxorubicin—prostate cancer	8.2e-05	0.000176	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CXCL12—prostate cancer	8.2e-05	0.00049	CbGpPWpGaD
Baclofen—Urticaria—Capecitabine—prostate cancer	8.2e-05	0.000176	CcSEcCtD
Baclofen—Ill-defined disorder—Epirubicin—prostate cancer	8.17e-05	0.000176	CcSEcCtD
Baclofen—Body temperature increased—Capecitabine—prostate cancer	8.16e-05	0.000175	CcSEcCtD
Baclofen—Abdominal pain—Capecitabine—prostate cancer	8.16e-05	0.000175	CcSEcCtD
Baclofen—Vomiting—Etoposide—prostate cancer	8.15e-05	0.000175	CcSEcCtD
Baclofen—Malnutrition—Doxorubicin—prostate cancer	8.15e-05	0.000175	CcSEcCtD
Baclofen—Anaemia—Epirubicin—prostate cancer	8.14e-05	0.000175	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HIF1A—prostate cancer	8.13e-05	0.000486	CbGpPWpGaD
Baclofen—Agitation—Epirubicin—prostate cancer	8.1e-05	0.000174	CcSEcCtD
Baclofen—Dyspepsia—Prednisone—prostate cancer	8.09e-05	0.000174	CcSEcCtD
Baclofen—Rash—Etoposide—prostate cancer	8.09e-05	0.000174	CcSEcCtD
Baclofen—Dermatitis—Etoposide—prostate cancer	8.08e-05	0.000174	CcSEcCtD
Baclofen—Headache—Etoposide—prostate cancer	8.03e-05	0.000173	CcSEcCtD
Baclofen—Flatulence—Doxorubicin—prostate cancer	8.03e-05	0.000173	CcSEcCtD
Baclofen—Decreased appetite—Prednisone—prostate cancer	7.99e-05	0.000172	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—prostate cancer	7.98e-05	0.000171	CcSEcCtD
Baclofen—Malaise—Epirubicin—prostate cancer	7.94e-05	0.000171	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—LEP—prostate cancer	7.93e-05	0.000474	CbGpPWpGaD
Baclofen—Fatigue—Prednisone—prostate cancer	7.93e-05	0.00017	CcSEcCtD
Baclofen—Vertigo—Epirubicin—prostate cancer	7.91e-05	0.00017	CcSEcCtD
Baclofen—Syncope—Epirubicin—prostate cancer	7.9e-05	0.00017	CcSEcCtD
Baclofen—Back pain—Doxorubicin—prostate cancer	7.88e-05	0.000169	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CAV1—prostate cancer	7.86e-05	0.00047	CbGpPWpGaD
Baclofen—Constipation—Prednisone—prostate cancer	7.86e-05	0.000169	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—prostate cancer	7.81e-05	0.000467	CbGpPWpGaD
Baclofen—Palpitations—Epirubicin—prostate cancer	7.78e-05	0.000167	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—KDR—prostate cancer	7.77e-05	0.000464	CbGpPWpGaD
Baclofen—Loss of consciousness—Epirubicin—prostate cancer	7.74e-05	0.000166	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CASP9—prostate cancer	7.72e-05	0.000461	CbGpPWpGaD
Baclofen—Vision blurred—Doxorubicin—prostate cancer	7.68e-05	0.000165	CcSEcCtD
Baclofen—Asthenia—Docetaxel—prostate cancer	7.65e-05	0.000164	CcSEcCtD
Baclofen—Convulsion—Epirubicin—prostate cancer	7.63e-05	0.000164	CcSEcCtD
Baclofen—Nausea—Etoposide—prostate cancer	7.62e-05	0.000164	CcSEcCtD
Baclofen—Hypertension—Epirubicin—prostate cancer	7.61e-05	0.000163	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ESR1—prostate cancer	7.58e-05	0.000453	CbGpPWpGaD
Baclofen—Feeling abnormal—Prednisone—prostate cancer	7.57e-05	0.000163	CcSEcCtD
Baclofen—Ill-defined disorder—Doxorubicin—prostate cancer	7.56e-05	0.000162	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CD—prostate cancer	7.56e-05	0.000452	CbGpPWpGaD
Baclofen—Pruritus—Docetaxel—prostate cancer	7.54e-05	0.000162	CcSEcCtD
Baclofen—Anaemia—Doxorubicin—prostate cancer	7.53e-05	0.000162	CcSEcCtD
Baclofen—Gastrointestinal pain—Prednisone—prostate cancer	7.52e-05	0.000161	CcSEcCtD
Baclofen—Chest pain—Epirubicin—prostate cancer	7.5e-05	0.000161	CcSEcCtD
Baclofen—Myalgia—Epirubicin—prostate cancer	7.5e-05	0.000161	CcSEcCtD
Baclofen—Agitation—Doxorubicin—prostate cancer	7.49e-05	0.000161	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NGFR—prostate cancer	7.48e-05	0.000447	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCQ—prostate cancer	7.48e-05	0.000447	CbGpPWpGaD
Baclofen—Anxiety—Epirubicin—prostate cancer	7.47e-05	0.000161	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.45e-05	0.00016	CcSEcCtD
Baclofen—Discomfort—Epirubicin—prostate cancer	7.41e-05	0.000159	CcSEcCtD
Baclofen—Asthenia—Capecitabine—prostate cancer	7.4e-05	0.000159	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—BAD—prostate cancer	7.39e-05	0.000442	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAP3K7—prostate cancer	7.39e-05	0.000442	CbGpPWpGaD
Baclofen—Malaise—Doxorubicin—prostate cancer	7.35e-05	0.000158	CcSEcCtD
Baclofen—Dry mouth—Epirubicin—prostate cancer	7.33e-05	0.000158	CcSEcCtD
Baclofen—Vertigo—Doxorubicin—prostate cancer	7.32e-05	0.000157	CcSEcCtD
Baclofen—Syncope—Doxorubicin—prostate cancer	7.31e-05	0.000157	CcSEcCtD
Baclofen—Urticaria—Prednisone—prostate cancer	7.3e-05	0.000157	CcSEcCtD
Baclofen—Pruritus—Capecitabine—prostate cancer	7.3e-05	0.000157	CcSEcCtD
Baclofen—Diarrhoea—Docetaxel—prostate cancer	7.29e-05	0.000157	CcSEcCtD
Baclofen—Abdominal pain—Prednisone—prostate cancer	7.27e-05	0.000156	CcSEcCtD
Baclofen—Body temperature increased—Prednisone—prostate cancer	7.27e-05	0.000156	CcSEcCtD
Baclofen—Confusional state—Epirubicin—prostate cancer	7.25e-05	0.000156	CcSEcCtD
Baclofen—Palpitations—Doxorubicin—prostate cancer	7.2e-05	0.000155	CcSEcCtD
Baclofen—Oedema—Epirubicin—prostate cancer	7.19e-05	0.000154	CcSEcCtD
Baclofen—Loss of consciousness—Doxorubicin—prostate cancer	7.16e-05	0.000154	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—APC—prostate cancer	7.16e-05	0.000428	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—prostate cancer	7.16e-05	0.000428	CbGpPWpGaD
Baclofen—Infection—Epirubicin—prostate cancer	7.14e-05	0.000153	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGF10—prostate cancer	7.11e-05	0.000425	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGF—prostate cancer	7.08e-05	0.000423	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IRS1—prostate cancer	7.08e-05	0.000423	CbGpPWpGaD
Baclofen—Shock—Epirubicin—prostate cancer	7.07e-05	0.000152	CcSEcCtD
Baclofen—Convulsion—Doxorubicin—prostate cancer	7.06e-05	0.000152	CcSEcCtD
Baclofen—Diarrhoea—Capecitabine—prostate cancer	7.06e-05	0.000152	CcSEcCtD
Baclofen—Nervous system disorder—Epirubicin—prostate cancer	7.05e-05	0.000151	CcSEcCtD
Baclofen—Dizziness—Docetaxel—prostate cancer	7.05e-05	0.000151	CcSEcCtD
Baclofen—Hypertension—Doxorubicin—prostate cancer	7.04e-05	0.000151	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ADRB2—prostate cancer	7.04e-05	0.00042	CbGpPWpGaD
Baclofen—Tachycardia—Epirubicin—prostate cancer	7.02e-05	0.000151	CcSEcCtD
Baclofen—Skin disorder—Epirubicin—prostate cancer	6.98e-05	0.00015	CcSEcCtD
Baclofen—Hyperhidrosis—Epirubicin—prostate cancer	6.95e-05	0.000149	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—JAK2—prostate cancer	6.94e-05	0.000415	CbGpPWpGaD
Baclofen—Myalgia—Doxorubicin—prostate cancer	6.94e-05	0.000149	CcSEcCtD
Baclofen—Chest pain—Doxorubicin—prostate cancer	6.94e-05	0.000149	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—prostate cancer	6.92e-05	0.000149	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—MAP2K1—prostate cancer	6.91e-05	0.000413	CbGpPWpGaD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.89e-05	0.000148	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—GSK3B—prostate cancer	6.87e-05	0.000411	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CD—prostate cancer	6.87e-05	0.00041	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VAV3—prostate cancer	6.86e-05	0.00041	CbGpPWpGaD
Baclofen—Discomfort—Doxorubicin—prostate cancer	6.86e-05	0.000147	CcSEcCtD
Baclofen—Anorexia—Epirubicin—prostate cancer	6.85e-05	0.000147	CcSEcCtD
Baclofen—Dizziness—Capecitabine—prostate cancer	6.82e-05	0.000147	CcSEcCtD
Baclofen—Dry mouth—Doxorubicin—prostate cancer	6.79e-05	0.000146	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—INS—prostate cancer	6.78e-05	0.000405	CbGpPWpGaD
Baclofen—Vomiting—Docetaxel—prostate cancer	6.78e-05	0.000146	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TGFBR2—prostate cancer	6.76e-05	0.000404	CbGpPWpGaD
Baclofen—Rash—Docetaxel—prostate cancer	6.72e-05	0.000144	CcSEcCtD
Baclofen—Hypotension—Epirubicin—prostate cancer	6.72e-05	0.000144	CcSEcCtD
Baclofen—Dermatitis—Docetaxel—prostate cancer	6.71e-05	0.000144	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—prostate cancer	6.71e-05	0.000144	CcSEcCtD
Baclofen—Headache—Docetaxel—prostate cancer	6.68e-05	0.000143	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ITPR1—prostate cancer	6.65e-05	0.000398	CbGpPWpGaD
Baclofen—Oedema—Doxorubicin—prostate cancer	6.65e-05	0.000143	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CREBBP—prostate cancer	6.64e-05	0.000397	CbGpPWpGaD
Baclofen—Infection—Doxorubicin—prostate cancer	6.61e-05	0.000142	CcSEcCtD
Baclofen—Asthenia—Prednisone—prostate cancer	6.6e-05	0.000142	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CB—prostate cancer	6.59e-05	0.000394	CbGpPWpGaD
Baclofen—Vomiting—Capecitabine—prostate cancer	6.56e-05	0.000141	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—IGF1—prostate cancer	6.56e-05	0.000392	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.55e-05	0.000141	CcSEcCtD
Baclofen—Shock—Doxorubicin—prostate cancer	6.54e-05	0.000141	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—EGFR—prostate cancer	6.52e-05	0.00039	CbGpPWpGaD
Baclofen—Nervous system disorder—Doxorubicin—prostate cancer	6.52e-05	0.00014	CcSEcCtD
Baclofen—Rash—Capecitabine—prostate cancer	6.51e-05	0.00014	CcSEcCtD
Baclofen—Pruritus—Prednisone—prostate cancer	6.5e-05	0.00014	CcSEcCtD
Baclofen—Insomnia—Epirubicin—prostate cancer	6.5e-05	0.00014	CcSEcCtD
Baclofen—Dermatitis—Capecitabine—prostate cancer	6.5e-05	0.00014	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—prostate cancer	6.49e-05	0.000139	CcSEcCtD
Baclofen—Headache—Capecitabine—prostate cancer	6.46e-05	0.000139	CcSEcCtD
Baclofen—Skin disorder—Doxorubicin—prostate cancer	6.46e-05	0.000139	CcSEcCtD
Baclofen—Paraesthesia—Epirubicin—prostate cancer	6.46e-05	0.000139	CcSEcCtD
Baclofen—Hyperhidrosis—Doxorubicin—prostate cancer	6.43e-05	0.000138	CcSEcCtD
Baclofen—Dyspnoea—Epirubicin—prostate cancer	6.41e-05	0.000138	CcSEcCtD
Baclofen—Somnolence—Epirubicin—prostate cancer	6.39e-05	0.000137	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—IGF1R—prostate cancer	6.36e-05	0.00038	CbGpPWpGaD
Baclofen—Anorexia—Doxorubicin—prostate cancer	6.34e-05	0.000136	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MAP2K1—prostate cancer	6.34e-05	0.000379	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—prostate cancer	6.33e-05	0.000378	CbGpPWpGaD
Baclofen—Nausea—Docetaxel—prostate cancer	6.33e-05	0.000136	CcSEcCtD
Baclofen—Dyspepsia—Epirubicin—prostate cancer	6.33e-05	0.000136	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	6.32e-05	0.000377	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—JAK2—prostate cancer	6.3e-05	0.000377	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CD—prostate cancer	6.29e-05	0.000376	CbGpPWpGaD
Baclofen—Diarrhoea—Prednisone—prostate cancer	6.29e-05	0.000135	CcSEcCtD
Baclofen—Decreased appetite—Epirubicin—prostate cancer	6.25e-05	0.000134	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—prostate cancer	6.24e-05	0.000373	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SERPINE1—prostate cancer	6.23e-05	0.000372	CbGpPWpGaD
Baclofen—Hypotension—Doxorubicin—prostate cancer	6.22e-05	0.000134	CcSEcCtD
Baclofen—Gastrointestinal disorder—Epirubicin—prostate cancer	6.21e-05	0.000133	CcSEcCtD
Baclofen—Fatigue—Epirubicin—prostate cancer	6.2e-05	0.000133	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—KRAS—prostate cancer	6.16e-05	0.000368	CbGpPWpGaD
Baclofen—Constipation—Epirubicin—prostate cancer	6.15e-05	0.000132	CcSEcCtD
Baclofen—Pain—Epirubicin—prostate cancer	6.15e-05	0.000132	CcSEcCtD
Baclofen—Nausea—Capecitabine—prostate cancer	6.13e-05	0.000132	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—LPL—prostate cancer	6.1e-05	0.000364	CbGpPWpGaD
Baclofen—Dizziness—Prednisone—prostate cancer	6.08e-05	0.000131	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.06e-05	0.00013	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—IL2—prostate cancer	6.05e-05	0.000362	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFRB—prostate cancer	6.05e-05	0.000361	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF2—prostate cancer	6.03e-05	0.00036	CbGpPWpGaD
Baclofen—Insomnia—Doxorubicin—prostate cancer	6.02e-05	0.000129	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CB—prostate cancer	5.99e-05	0.000358	CbGpPWpGaD
Baclofen—Paraesthesia—Doxorubicin—prostate cancer	5.97e-05	0.000128	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NOS3—prostate cancer	5.94e-05	0.000355	CbGpPWpGaD
Baclofen—Dyspnoea—Doxorubicin—prostate cancer	5.93e-05	0.000127	CcSEcCtD
Baclofen—Feeling abnormal—Epirubicin—prostate cancer	5.92e-05	0.000127	CcSEcCtD
Baclofen—Somnolence—Doxorubicin—prostate cancer	5.91e-05	0.000127	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ITGB3—prostate cancer	5.89e-05	0.000352	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Epirubicin—prostate cancer	5.88e-05	0.000126	CcSEcCtD
Baclofen—Dyspepsia—Doxorubicin—prostate cancer	5.86e-05	0.000126	CcSEcCtD
Baclofen—Vomiting—Prednisone—prostate cancer	5.84e-05	0.000126	CcSEcCtD
Baclofen—Rash—Prednisone—prostate cancer	5.8e-05	0.000125	CcSEcCtD
Baclofen—Dermatitis—Prednisone—prostate cancer	5.79e-05	0.000124	CcSEcCtD
Baclofen—Decreased appetite—Doxorubicin—prostate cancer	5.78e-05	0.000124	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—JAK2—prostate cancer	5.78e-05	0.000345	CbGpPWpGaD
Baclofen—Headache—Prednisone—prostate cancer	5.76e-05	0.000124	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—prostate cancer	5.75e-05	0.000344	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.74e-05	0.000123	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—prostate cancer	5.74e-05	0.000123	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ERBB3—prostate cancer	5.71e-05	0.000341	CbGpPWpGaD
Baclofen—Urticaria—Epirubicin—prostate cancer	5.71e-05	0.000123	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGFR2—prostate cancer	5.71e-05	0.000341	CbGpPWpGaD
Baclofen—Constipation—Doxorubicin—prostate cancer	5.69e-05	0.000122	CcSEcCtD
Baclofen—Pain—Doxorubicin—prostate cancer	5.69e-05	0.000122	CcSEcCtD
Baclofen—Body temperature increased—Epirubicin—prostate cancer	5.68e-05	0.000122	CcSEcCtD
Baclofen—Abdominal pain—Epirubicin—prostate cancer	5.68e-05	0.000122	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—prostate cancer	5.66e-05	0.000338	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MDM2—prostate cancer	5.64e-05	0.000337	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB2—prostate cancer	5.56e-05	0.000332	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2—prostate cancer	5.5e-05	0.000328	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CB—prostate cancer	5.49e-05	0.000328	CbGpPWpGaD
Baclofen—Feeling abnormal—Doxorubicin—prostate cancer	5.48e-05	0.000118	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TERT—prostate cancer	5.48e-05	0.000327	CbGpPWpGaD
Baclofen—Nausea—Prednisone—prostate cancer	5.46e-05	0.000117	CcSEcCtD
Baclofen—Gastrointestinal pain—Doxorubicin—prostate cancer	5.44e-05	0.000117	CcSEcCtD
Baclofen—Urticaria—Doxorubicin—prostate cancer	5.28e-05	0.000114	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CXCL8—prostate cancer	5.27e-05	0.000315	CbGpPWpGaD
Baclofen—Body temperature increased—Doxorubicin—prostate cancer	5.26e-05	0.000113	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—prostate cancer	5.26e-05	0.000113	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—HIF1A—prostate cancer	5.24e-05	0.000313	CbGpPWpGaD
Baclofen—Asthenia—Epirubicin—prostate cancer	5.16e-05	0.000111	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CDKN1B—prostate cancer	5.15e-05	0.000308	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LEP—prostate cancer	5.11e-05	0.000306	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—prostate cancer	5.09e-05	0.000304	CbGpPWpGaD
Baclofen—Pruritus—Epirubicin—prostate cancer	5.09e-05	0.000109	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CAV1—prostate cancer	5.07e-05	0.000303	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—prostate cancer	5.05e-05	0.000302	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2—prostate cancer	5.04e-05	0.000301	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.02e-05	0.0003	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—prostate cancer	5.01e-05	0.0003	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KDR—prostate cancer	5.01e-05	0.000299	CbGpPWpGaD
Baclofen—Diarrhoea—Epirubicin—prostate cancer	4.92e-05	0.000106	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCND1—prostate cancer	4.91e-05	0.000294	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ESR1—prostate cancer	4.88e-05	0.000292	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CTNNB1—prostate cancer	4.86e-05	0.000291	CbGpPWpGaD
Baclofen—Asthenia—Doxorubicin—prostate cancer	4.77e-05	0.000103	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MMP9—prostate cancer	4.77e-05	0.000285	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BAD—prostate cancer	4.76e-05	0.000285	CbGpPWpGaD
Baclofen—Dizziness—Epirubicin—prostate cancer	4.75e-05	0.000102	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CDKN1A—prostate cancer	4.75e-05	0.000284	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTEN—prostate cancer	4.74e-05	0.000283	CbGpPWpGaD
Baclofen—Pruritus—Doxorubicin—prostate cancer	4.71e-05	0.000101	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AKT1—prostate cancer	4.63e-05	0.000276	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—prostate cancer	4.61e-05	0.000276	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APC—prostate cancer	4.61e-05	0.000276	CbGpPWpGaD
Baclofen—Vomiting—Epirubicin—prostate cancer	4.57e-05	9.82e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—IRS1—prostate cancer	4.56e-05	0.000273	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGF—prostate cancer	4.56e-05	0.000273	CbGpPWpGaD
Baclofen—Diarrhoea—Doxorubicin—prostate cancer	4.55e-05	9.78e-05	CcSEcCtD
Baclofen—Rash—Epirubicin—prostate cancer	4.53e-05	9.74e-05	CcSEcCtD
Baclofen—Dermatitis—Epirubicin—prostate cancer	4.53e-05	9.73e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—EP300—prostate cancer	4.52e-05	0.00027	CbGpPWpGaD
Baclofen—Headache—Epirubicin—prostate cancer	4.5e-05	9.68e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—GSK3B—prostate cancer	4.43e-05	0.000265	CbGpPWpGaD
Baclofen—Dizziness—Doxorubicin—prostate cancer	4.4e-05	9.45e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SRC—prostate cancer	4.4e-05	0.000263	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—INS—prostate cancer	4.37e-05	0.000261	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—prostate cancer	4.28e-05	0.000256	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CREBBP—prostate cancer	4.28e-05	0.000256	CbGpPWpGaD
Baclofen—Nausea—Epirubicin—prostate cancer	4.27e-05	9.17e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—STAT3—prostate cancer	4.24e-05	0.000253	CbGpPWpGaD
Baclofen—Vomiting—Doxorubicin—prostate cancer	4.23e-05	9.09e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—IGF1—prostate cancer	4.22e-05	0.000252	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—prostate cancer	4.2e-05	0.000251	CbGpPWpGaD
Baclofen—Rash—Doxorubicin—prostate cancer	4.19e-05	9.01e-05	CcSEcCtD
Baclofen—Dermatitis—Doxorubicin—prostate cancer	4.19e-05	9e-05	CcSEcCtD
Baclofen—Headache—Doxorubicin—prostate cancer	4.17e-05	8.95e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MAP2K1—prostate cancer	4.08e-05	0.000244	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CD—prostate cancer	4.06e-05	0.000242	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—prostate cancer	4.02e-05	0.00024	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SERPINE1—prostate cancer	4.01e-05	0.00024	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KRAS—prostate cancer	3.97e-05	0.000237	CbGpPWpGaD
Baclofen—Nausea—Doxorubicin—prostate cancer	3.95e-05	8.49e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MYC—prostate cancer	3.94e-05	0.000235	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFB1—prostate cancer	3.93e-05	0.000235	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF2—prostate cancer	3.88e-05	0.000232	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—prostate cancer	3.85e-05	0.00023	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOS3—prostate cancer	3.83e-05	0.000229	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JAK2—prostate cancer	3.72e-05	0.000222	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—prostate cancer	3.65e-05	0.000218	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—prostate cancer	3.64e-05	0.000218	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MDM2—prostate cancer	3.63e-05	0.000217	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB2—prostate cancer	3.58e-05	0.000214	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CB—prostate cancer	3.54e-05	0.000211	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—prostate cancer	3.4e-05	0.000203	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—prostate cancer	3.34e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1B—prostate cancer	3.32e-05	0.000198	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—prostate cancer	3.28e-05	0.000196	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASP3—prostate cancer	3.25e-05	0.000194	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—prostate cancer	3.25e-05	0.000194	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—prostate cancer	3.24e-05	0.000193	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—prostate cancer	3.23e-05	0.000193	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCND1—prostate cancer	3.17e-05	0.000189	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CTNNB1—prostate cancer	3.13e-05	0.000187	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—prostate cancer	3.07e-05	0.000184	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1A—prostate cancer	3.06e-05	0.000183	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTEN—prostate cancer	3.06e-05	0.000183	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—prostate cancer	2.98e-05	0.000178	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—prostate cancer	2.96e-05	0.000177	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EP300—prostate cancer	2.91e-05	0.000174	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SRC—prostate cancer	2.83e-05	0.000169	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—prostate cancer	2.76e-05	0.000165	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—prostate cancer	2.73e-05	0.000163	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—prostate cancer	2.73e-05	0.000163	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—prostate cancer	2.54e-05	0.000152	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TGFB1—prostate cancer	2.53e-05	0.000151	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—prostate cancer	2.48e-05	0.000148	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KRAS—prostate cancer	2.35e-05	0.00014	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—prostate cancer	2.16e-05	0.000129	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—prostate cancer	2.09e-05	0.000125	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—prostate cancer	1.91e-05	0.000114	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—prostate cancer	1.76e-05	0.000105	CbGpPWpGaD
